physostigmine has been researched along with Nervous System Disorders in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (75.00) | 18.7374 |
1990's | 3 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
SOROKHTIN, GN | 1 |
COHEN, A; GOLDMAN, J; TROMMER, P | 1 |
Edge, PC; Grell, GA; Melville, GN; Wray, SR | 1 |
Cooper, GH; Gordon, JJ; Inns, RH; Johnson, MK; Leadbeater, L; Maidment, MP; Rickard, RL; Upshall, DG | 1 |
Irwin, HA; Preskorn, SH | 1 |
Fukushima, M; Horiguchi, H; Konno, N; Suzuki, N | 1 |
Keesey, JC | 1 |
Goldbarg, A; Klawans, HL; Kramer, J; Weisdorf, D | 1 |
Dworacek, B; Rupreht, J | 1 |
Baldessarini, RJ; Granacher, RP | 1 |
Adams, N; Corcoran, K; Kaminskis, A; Maitland, G; von Bredow, J; Wade, J | 1 |
Campbell, GA; Davis, KL; Haroutunian, V; Kanof, PD; Tsuboyama, GK | 1 |
1 review(s) available for physostigmine and Nervous System Disorders
Article | Year |
---|---|
Current concepts of abnormal motor disorder: an experimental model of attentional deficit disorder.
Topics: Amphetamine; Animals; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Avoidance Learning; Brain; Cholinesterase Inhibitors; Dyskinesia, Drug-Induced; gamma-Aminobutyric Acid; Humans; Huntington Disease; Hyperkinesis; Models, Neurological; Movement Disorders; Nervous System Diseases; Neurotransmitter Agents; Parkinson Disease; Physostigmine; Rats | 1981 |
11 other study(ies) available for physostigmine and Nervous System Disorders
Article | Year |
---|---|
[Theory of eserine therapy in organic diseases of the central nervous system].
Topics: Central Nervous System; Nervous System Diseases; Physostigmine | 1946 |
Physostigmine for muscle spasm in rheumatoid arthritis.
Topics: Arthritis; Arthritis, Rheumatoid; Humans; Nervous System Diseases; Physostigmine; Spasm | 1946 |
The delayed neuropathic effects of nerve agents and some other organophosphorus compounds.
Topics: Acetylcholinesterase; Animals; Atropine; Brain; Carboxylic Ester Hydrolases; Chemical Warfare; Chickens; Cholinesterase Inhibitors; Isoflurophate; Lethal Dose 50; Nervous System Diseases; Organophosphorus Compounds; Physostigmine | 1983 |
Toxicity of tricyclic antidepressants--kinetics, mechanism, intervention: a review.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Arrhythmias, Cardiac; Child; Dose-Response Relationship, Drug; Humans; Lidocaine; Metabolic Clearance Rate; Myocardial Contraction; Nervous System Diseases; Physostigmine; Propranolol; Risk | 1982 |
Characterization of high-affinity binding sites for diisopropylfluorophosphate (DFP) from chicken spinal cord membranes.
Topics: Animals; Binding Sites; Chickens; Chromatography, Gel; Isoflurophate; Nervous System Diseases; Physostigmine; Spinal Cord; Tritolyl Phosphates | 1994 |
Contemporary opinions about Mary Walker: a shy pioneer of therapeutic neurology.
Topics: Cholinesterase Inhibitors; History, 19th Century; History, 20th Century; Humans; Myasthenia Gravis; Neostigmine; Nervous System Diseases; Neurology; Physostigmine | 1998 |
Physostigmine for cardiac and neurologic manifestations of phenothiazine poisoning.
Topics: Antipsychotic Agents; Arrhythmias, Cardiac; Electrocardiography; Humans; Male; Middle Aged; Nervous System Diseases; Parasympatholytics; Physostigmine; Trifluoperazine | 1978 |
Central anticholinergic syndrome in anesthetic practice.
Topics: Adolescent; Adult; Aged; Anesthesia; Central Nervous System Diseases; Child; Child, Preschool; Female; Humans; Male; Middle Aged; Nervous System Diseases; Parasympathetic Nervous System; Parasympatholytics; Physostigmine; Synapses | 1976 |
Physostigmine. Its use in acute anticholinergic syndrome with antidepressant and antiparkinson drugs.
Topics: Acute Disease; Adult; Amitriptyline; Benztropine; Chemical Phenomena; Chemistry; Cholinesterase Inhibitors; Doxepin; Female; Haloperidol; Humans; Male; Nervous System Diseases; Parasympatholytics; Physostigmine; Psychoses, Substance-Induced; Syndrome; Thioridazine | 1975 |
Efficacy evaluation of physostigmine and anticholinergic adjuncts as a pretreatment for nerve agent intoxication.
Topics: Animals; Cholinesterases; Erythrocytes; Female; Lethal Dose 50; Macaca fascicularis; Male; Nervous System Diseases; Parasympatholytics; Physostigmine; Scopolamine; Soman; Trihexyphenidyl | 1991 |
Animal models of Alzheimer's disease: behavior, pharmacology, transplants.
Topics: 4-Aminopyridine; Alzheimer Disease; Aminopyridines; Animals; Behavior, Animal; Brain; Disease Models, Animal; Fetus; Growth Substances; Humans; Nerve Growth Factors; Nerve Tissue; Nerve Tissue Proteins; Nervous System Diseases; Norepinephrine; Parasympathetic Nervous System; Physostigmine; Somatostatin | 1986 |